Breaking: Lykos Lays Off 75% of Staff, Ropes In Pharma Veteran, Doblin Resigns Board

Finance

Reading Time: < 1 minute

Following FDA’s rejection of Lykos Therapeutics’ MDMA-assisted therapy for PTSD New Drug Application (NDA), the company has today announced a significant reorganisation. The overhaul sees around 75% of the company’s workforce laid off, with the remaining skeleton team focused on “ongoing clinical development, medical affairs, and engagement with the FDA.” As the company prepared for a…
Source

Source link

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Name
This field is for validation purposes and should be left unchanged.

Subscribe to receive the latest business and industry news in your inbox.

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Comments
This field is for validation purposes and should be left unchanged.

latest from the industry

PSYCHEDELICS news

Curtin University, Draslovka partner to advance glycine leaching technology

Reading Time: < 1 minute“The non-toxic amino acid has the potential to replace hazardous chemicals like cyanide in mineral

November 23, 2024

Psychedelic Santa Cruz – Using Psychedelics Daily for a happy & healthy life

Reading Time: < 1 minuteOur mission is to create community surrounding psychedelics, mental health, and spiritual growth. We’ll be

November 22, 2024

How to Process Payments for Your Cannabis Dispensary

Reading Time: 4 minutesHow to Process Payments for Your Cannabis Dispensary Cannabis dispensaries are becoming more common as